The global Gastroesophageal Reflux Disease Therapeutics market size is expected to be worth around US$ 14.34 billion by 2030, according to a new report by Vision Research Reports.
The global Gastroesophageal Reflux Disease Therapeutics market size was valued at US$ 15.66 billion in 2020 and is anticipated to grow at a CAGR of 12.9% during forecast period 2021 to 2030.
Growth Factors
Growing number of companies worldwide increasingly being subjected to price scrutiny coupled with shift in government focus on promoting consumer accessibility will engender further drug price reductions. Although expiry of major patents has affected the market turnover, the demand for acid-reducing drugs, owing to the rising incidence of heartburn across the globe, is expected to escalate in the coming years.
While GERD devices serve as an alternative approach to managing heartburn, these devices have struggled owing to their low success rates and failed clinical trials. Hence, limited acceptance of GERD management devices have contributed to the increasing demand for acid neutralizing drugs as the major therapy approach.
However, GERD devices for minimally invasive procedures to address underlying anatomical defects are steadily gaining traction with growing supportive clinical evidence for devices to perform procedures, such as transoral fundoplication, which prevent reflux of acid and non-acid contents altogether. To further reinforce its adoption in the U.S., a new CPT code (43210) was established to facilitate the reimbursement process in 2020.
Report Highlights
Antacids held the dominant market share in the year 2020 and are to retain their top position throughout the forecast period. Antacids are preferred as first-line therapy for mild and infrequent symptoms as they neutralize gastric acid secretions immediately. Convenient over-the-counter availability of antacids in various forms such as tablets, powders, and syrups is responsible for their excessive adoption. In addition, the American Hospital Formulary, among other countries, enlists over 120 antacid preparations to advocate their use.
PPIs accounted for the second largest segment in 2020 as they are the most commonly prescribed medication type for heartburn. Inflow of generics following the loss of exclusivity of popular drugs, including Nexium and Prilosec, has affected the sales of branded PPIs. A further decline is looming large with the awaited expiration of other patent-protected therapeutics, such as Dexilant.
North America was identified as the largest regional segment in terms of market share for GERD therapeutics in the year 2016. In the U.S., every year, more than 80 million people experience GERD symptoms, of which, 25 million people suffer from heartburn or acid reflux daily and 60 million people on a monthly basis.
In addition, the number of outpatient clinic visits related to GERD in the U.S. has been increasing in the last few years stemming from the fact that the geriatric population is more prone to developing heartburn and acid reflux. Nearly 18% of the American population will be aged 65 and more by 2025.
On the other hand, the Asia Pacific region is projected to showcase the fastest growth rate over the forecast period. The rising geriatric population and lifestyle & dietary risk factors such as obesity & high fat diet, respectively, is expected to drive the market growth in this region. In developing countries, such as India and China, the trend of self treatment is rapidly growing due to the availability and affordability of OTC antacids.
Key Players
AstraZeneca PLC; Eisai Co., Ltd.; GlaxoSmithKline PLC; Takeda Pharmaceutical Co., Ltd.; and Johnson & Johnson account for the top players in the market. Moreover, Daewoong Pharmaceutical Co., Ltd.; Ironwood Pharmaceuticals, Inc.; SRS Pharmaceuticals Pvt. Ltd.; and SFJ Pharmaceuticals
Market Segmentation
Drug Type Outlook
Antacids
H2 Receptor Blockers
Proton Pump Inhibitors (PPIs)
Pro-kinetic agents
Regional Outlook
North America
U.S.
Canada
Europe
UK
Germany
Asia Pacific
Japan
China
Latin America
Brazil
MEA
South Africa
The Gastroesophageal Reflux Disease Therapeutics market research report covers definition, classification, product classification, product application, development trend, product technology, competitive landscape, industrial chain structure, industry overview, national policy and planning analysis of the industry, the latest dynamic analysis, etc., and also includes major. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.
The report provides size (in terms of volume and value) of Gastroesophageal Reflux Disease Therapeutics market for the base year 2020 and the forecast between 2021 and 2030. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.
This report focuses on the global Gastroesophageal Reflux Disease Therapeutics market status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Gastroesophageal Reflux Disease Therapeutics market development in United States, Europe and China.
It is pertinent to consider that in a volatile global economy, we haven’t just conducted Gastroesophageal Reflux Disease Therapeutics market forecasts in terms of CAGR, but also studied the market based on key parameters, including Year-on-Year (Y-o-Y) growth, to comprehend the certainty of the market and to find and present the lucrative opportunities in market.
In terms of production side, this report researches the Gastroesophageal Reflux Disease Therapeutics capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and type.
In terms of consumption side, this report focuses on the consumption of Gastroesophageal Reflux Disease Therapeutics by regions (countries) and application.
Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Gastroesophageal Reflux Disease Therapeutics market. These figures have been provided in terms of both revenue and volume for the period 2017 to 2030. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.
With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major Gastroesophageal Reflux Disease Therapeutics market companies.
Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of Gastroesophageal Reflux Disease Therapeutics market upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of market and consumption, major regions and Consumption, major Chinese producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.
The research in this report also includes product parameters, production process, cost structure, and data information classified by region, technology and application. Finally, the paper model new project SWOT analysis and investment feasibility study of the case model.
Overall, this is an in-depth research report specifically for the Gastroesophageal Reflux Disease Therapeutics industry. The research center uses an objective and fair way to conduct an in-depth analysis of the development trend of the industry, providing support and evidence for customer competition analysis, development planning, and investment decision-making. In the course of operation, the project has received support and assistance from technicians and marketing personnel in various links of the industry chain.
The Gastroesophageal Reflux Disease Therapeutics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to Gastroesophageal Reflux Disease Therapeutics market.
Prominent players in the market are predicted to face tough competition from the new entrants. However, some of the key players are targeting to acquire the startup companies in order to maintain their dominance in the global market. For a detailed analysis of key companies, their strengths, weaknesses, threats, and opportunities are measured in the report by using industry-standard tools such as the SWOT analysis. Regional coverage of key companies is covered in the report to measure their dominance. Key manufacturers of Gastroesophageal Reflux Disease Therapeutics market are focusing on introducing new products to meet the needs of the patrons. The feasibility of new products is also measured by using industry-standard tools.
Key companies are increasing their investments in research and development activities for the discovery of new products. There has also been a rise in the government funding for the introduction of new Gastroesophageal Reflux Disease Therapeutics market. These factors have benefited the growth of the global market for Gastroesophageal Reflux Disease Therapeutics. Going forward, key companies are predicted to benefit from the new product launches and the adoption of technological advancements. Technical advancements have benefited many industries and the global industry is not an exception.
New product launches and the expansion of already existing business are predicted to benefit the key players in maintaining their dominance in the global market for Gastroesophageal Reflux Disease Therapeutics. The global market is segmented on the basis of region, application, en-users and product type. Based on region, the market is divided into North America, Europe, Asia-Pacific, Latin America and Middle East and Africa (MEA).
In this study, the years considered to estimate the market size of Gastroesophageal Reflux Disease Therapeutics are as follows:
Reasons to Purchase this Report:
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value USD Million and volume Units Million data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
Research Methodology:
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
Market Size Estimation
Top-down and bottom-up approaches are used to estimate and validate the global market size for company, regional division, product type and application (end users).
The market estimations in this report are based on the selling price (excluding any discounts provided by the manufacturer, distributor, wholesaler or traders). Market share analysis, assigned to each of the segments and regions are achieved through product utilization rate and average selling price.
Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or others factors are accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Vision Research Reports and presented in this report.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation. Extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report.
Secondary Sources
Secondary Sources occupies approximately 25% of data sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on. This research study includes secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; investor presentations; and SEC filings of companies.
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
The study objectives of this report are:
To strategically profile the key players and comprehensively analyze their growth strategies.
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers